Theoretical Investigation of the Coronavirus SARS-CoV-2 (COVID-19) Infection Mechanism and Selectivity.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
24 Mar 2022
Historique:
received: 08 02 2022
revised: 07 03 2022
accepted: 17 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

The SARS-CoV-2 virus, commonly known as COVID-19, first occurred in December 2019 in Wuhan, Hubei Province, China. Since then, it has become a tremendous threat to human health. With a pandemic threat, it is in the significant interest of the scientific world to establish its method of infection. In this manuscript, we combine knowledge of the infection mechanism with theoretical methods to answer the question of the virus's selectivity. We proposed a two-stage infection mechanism. In the first step, the virus interacts with the ACE2 receptor, with the "proper strength". When the interaction is too strong, the virus will remain in an "improper position"; if the interaction is too weak, the virus will "run away" from the cell. We also indicated three residues (positions 30, 31, and 353) located on the ACE2 protein-binding interface, which seems to be crucial for successful infection. Our results indicate that these residues are necessary for the initiation of the infection process.

Identifiants

pubmed: 35408482
pii: molecules27072080
doi: 10.3390/molecules27072080
pmc: PMC9000624
pii:
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCN, Nationa Science Center, Poland
ID : 2017/26/M/ST4/00044

Références

Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
Sci Rep. 2021 Jun 24;11(1):13063
pubmed: 34168168
Cardiology. 2015;131(2):97-106
pubmed: 25896805
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5482-5
pubmed: 10318909
Adv Virus Res. 2019;105:93-116
pubmed: 31522710
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
Cell Res. 2013 Aug;23(8):986-93
pubmed: 23835475
Diabetes Metab Syndr. 2020 May - Jun;14(3):251-254
pubmed: 32247213
Eur Respir J. 2020 Jul 9;56(1):
pubmed: 32341103
Nat Commun. 2021 Apr 1;12(1):2144
pubmed: 33795662
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322
pubmed: 32826334
Sci Rep. 2020 Aug 26;10(1):14214
pubmed: 32848162
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
J Phys Chem B. 2005 Jul 21;109(28):13798-810
pubmed: 16852728
Int J Mol Sci. 2020 Sep 22;21(18):
pubmed: 32971906
Mil Med Res. 2020 Mar 13;7(1):11
pubmed: 32169119
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Clin Microbiol Rev. 2007 Oct;20(4):660-94
pubmed: 17934078
J Med Virol. 2020 Jul;92(7):719-725
pubmed: 32170865
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
Lancet. 2020 Oct 3;396(10256):937-939
pubmed: 33010824
Nucleic Acids Res. 2018 Mar 16;46(5):2699
pubmed: 29425356
Am J Obstet Gynecol MFM. 2020 May;2(2):100110
pubmed: 32518901
J Virol. 2021 Jan 28;95(4):
pubmed: 33219167
J Adv Res. 2020 Mar 16;24:91-98
pubmed: 32257431
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W665-7
pubmed: 15215472
Am J Obstet Gynecol MFM. 2020 May;2(2):100106
pubmed: 32363335
Nat Rev Drug Discov. 2016 May;15(5):327-47
pubmed: 26868298
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Nature. 2013 Nov 28;503(7477):535-8
pubmed: 24172901
Proteins. 2000 Aug 15;40(3):389-408
pubmed: 10861930
Nat Commun. 2020 Sep 11;11(1):4541
pubmed: 32917884
Acta Biochim Pol. 2015;62(3):629-31
pubmed: 26317128
J Chem Theory Comput. 2010 Jul 13;6(7):2191-203
pubmed: 26615945
Int J Infect Dis. 2020 May;94:128-132
pubmed: 32251805
Prog Mol Biol Transl Sci. 2020;170:73-122
pubmed: 32145953
Nucleic Acids Res. 2018 Jul 2;46(W1):W304-W309
pubmed: 29718313
J Transl Med. 2020 Sep 15;18(1):353
pubmed: 32933536
Protein Sci. 2018 Jan;27(1):112-128
pubmed: 28836357
Trends Endocrinol Metab. 2004 May-Jun;15(4):166-9
pubmed: 15109615
Curr Opin Virol. 2014 Jun;6:55-60
pubmed: 24762977
Circ Res. 2000 Sep 1;87(5):E1-9
pubmed: 10969042
Am J Respir Crit Care Med. 2018 Aug 15;198(4):422-423
pubmed: 29634285
J Gen Virol. 2020 Sep;101(9):921-924
pubmed: 32538738
J Virol. 2020 Jul 16;94(15):
pubmed: 32404529
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12593-12608
pubmed: 33336780
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Environ Sci Pollut Res Int. 2021 Apr;28(16):19589-19600
pubmed: 33655480
Biochem J. 2004 Sep 1;382(Pt 2):565-73
pubmed: 15175004
J Biol Chem. 2000 Oct 27;275(43):33238-43
pubmed: 10924499
J Med Virol. 2020 Jul;92(7):726-730
pubmed: 32221983
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
Circulation. 2003 Oct 7;108(14):1707-12
pubmed: 14504186
Gastroenterology. 2009 Mar;136(3):872-82
pubmed: 19185582
mBio. 2021 Mar 30;12(2):
pubmed: 33785634
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
J Gene Med. 2021 Feb;23(2):e3303
pubmed: 33305456

Auteurs

Iga Biskupek (I)

Faculty of Chemistry, University of Gdansk, ul. Wita Stwosza 63, 80-308 Gdansk, Poland.

Adam Sieradzan (A)

Faculty of Chemistry, University of Gdansk, ul. Wita Stwosza 63, 80-308 Gdansk, Poland.

Cezary Czaplewski (C)

Faculty of Chemistry, University of Gdansk, ul. Wita Stwosza 63, 80-308 Gdansk, Poland.

Adam Liwo (A)

Faculty of Chemistry, University of Gdansk, ul. Wita Stwosza 63, 80-308 Gdansk, Poland.

Adam Lesner (A)

Faculty of Chemistry, University of Gdansk, ul. Wita Stwosza 63, 80-308 Gdansk, Poland.

Artur Giełdoń (A)

Faculty of Chemistry, University of Gdansk, ul. Wita Stwosza 63, 80-308 Gdansk, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH